Aclarion ROE 2021-2024 | ACON
Aclarion ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-06-30 | $-0.01B | $0.00B | -666.67% |
2024-03-31 | $-0.01B | $0.00B | -2000.00% |
2023-12-31 | $-0.00B | $-0.00B | 1600.00% |
2023-09-30 | $-0.00B | $-0.00B | -800.00% |
2023-06-30 | $-0.01B | $0.00B | -333.33% |
2023-03-31 | $-0.01B | $0.00B | -320.00% |
2022-12-31 | $-0.01B | $0.00B | -1600.00% |
2022-09-30 | $-0.01B | $0.00B | 533.33% |
2022-06-30 | $-0.01B | $0.00B | 400.00% |
2022-03-31 | $-0.01B | $-0.01B | 184.62% |
2021-12-31 | $-0.01B | $-0.01B | 400.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.002B | $0.000B |
Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $98.630B | 12.24 |
Cencora (COR) | United States | $46.202B | 17.66 |
DiDi Global (DIDIY) | China | $23.330B | 0.00 |
ICON (ICLR) | Ireland | $18.188B | 16.34 |
Avantor (AVTR) | United States | $15.249B | 22.89 |
Natera (NTRA) | United States | $14.554B | 0.00 |
Revvity (RVTY) | United States | $14.348B | 25.13 |
Viatris (VTRS) | United States | $13.654B | 4.16 |
BioMerieux (BMXMF) | France | $13.361B | 0.00 |
Solventum (SOLV) | United States | $12.641B | 0.00 |
CochLear (CHEOY) | Australia | $12.413B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.264B | 28.92 |
Charles River Laboratories (CRL) | United States | $9.403B | 17.77 |
Sonic Healthcare (SKHHY) | Australia | $8.777B | 0.00 |
HealthEquity (HQY) | United States | $7.691B | 41.74 |
Doximity (DOCS) | United States | $7.659B | 48.53 |
Bausch + Lomb (BLCO) | Canada | $7.204B | 31.00 |
PACS (PACS) | United States | $6.415B | 0.00 |
Life Times (LTH) | United States | $4.688B | 32.21 |
Organon (OGN) | United States | $4.418B | 4.49 |
Sotera Health (SHC) | United States | $4.359B | 21.99 |
Surgery Partners (SGRY) | United States | $3.746B | 41.51 |
BrightSpring Health Services (BTSG) | United States | $2.658B | 0.00 |
Concentras Parent (CON) | United States | $2.647B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.533B | 0.00 |
GoodRx Holdings (GDRX) | United States | $2.356B | 88.71 |
Alignment Healthcare (ALHC) | United States | $2.112B | 0.00 |
Premier (PINC) | United States | $1.980B | 8.90 |
Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
GeneDx Holdings (WGS) | United States | $1.584B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.508B | 7.57 |
Teladoc Health (TDOC) | United States | $1.467B | 0.00 |
Progyny (PGNY) | United States | $1.395B | 24.52 |
Establishment Labs Holdings (ESTA) | $1.247B | 0.00 | |
CareDx (CDNA) | United States | $1.181B | 0.00 |
Pediatrix Medical (MD) | United States | $1.066B | 11.60 |
Agilon Health (AGL) | United States | $1.062B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.936B | 24.50 |
Embecta (EMBC) | United States | $0.802B | 5.35 |
InnovAge Holding (INNV) | United States | $0.768B | 0.00 |
SBC Medicals (SBC) | United States | $0.737B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
Enhabit (EHAB) | United States | $0.354B | 30.61 |
DocGo (DCGO) | United States | $0.350B | 13.15 |
Biodesix (BDSX) | United States | $0.238B | 0.00 |
Sera Prognostics (SERA) | United States | $0.232B | 0.00 |
ModivCare (MODV) | United States | $0.205B | 6.52 |
Beauty Health (SKIN) | United States | $0.205B | 0.00 |
LifeMD (LFMD) | United States | $0.185B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.184B | 0.00 |
MultiPlan (MPLN) | United States | $0.156B | 0.00 |
Nutex Health (NUTX) | United States | $0.123B | 0.00 |
So-Young (SY) | China | $0.104B | 25.12 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.051B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.69 |
Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.035B | 0.00 |
Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
Oncology Institute (TOI) | United States | $0.025B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
KindlyMD (KDLY) | United States | $0.006B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |